Demographics (2)
- AGE - Age of subject at enrollment (phv00525412.v1.p1)
- SEX - Biological sex (phv00525406.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for chronic lymphocytic leukemia (CLL); all subjects are CLL patients. (phv00525410.v1.p1)
Race and Ethnicity (1)
- RACE - Race of subject (phv00525411.v1.p1)
Other (21)
- ANALYTE_TYPE - Analyte Type (phv00525423.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00525422.v1.p1)
- BTK_MUT - Somatic mutation in BTK during treatment (phv00525415.v1.p1)
- COMPLEX_KARYOTYPE - Complex karyotype in the malignant B cells (phv00525420.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00525405.v1.p1)
- FISH_+12 - Somatic trisomy 12 detected by FISH assay (phv00525417.v1.p1)
- FISH_del11q - Somatic deletion in 11q detected by FISH assay (phv00525418.v1.p1)
- FISH_del13q - Somatic deletion in 13q detected by FISH assay (phv00525416.v1.p1)
- FISH_del17p - Somatic deletion in 17p detected by FISH assay (phv00525419.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00525425.v1.p1)
- IGH - IGHV status of malignant B cells (phv00525413.v1.p1)
- IS_TUMOR - Tumor status (phv00525424.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00525426.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00525427.v1.p1)
- SAMPLE_ID - Sample ID (phv00525421.v1.p1)
- SAMPLE_ID - Sample ID (phv00525408.v1.p1)
- SUBJECT_ID - Subject ID (phv00525409.v1.p1)
- SUBJECT_ID - Subject ID (phv00525404.v1.p1)
- SUBJECT_ID - Subject ID (phv00525407.v1.p1)
- TP53_MUT - Somatic mutation in TP53 (phv00525414.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00525428.v1.p1)